A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers
Hui Gan, Sagun Parakh, F. T. Lee, Niall C. Tebbutt, Malaka Ameratunga, Sze Ting Lee, Graeme O’Keefe, Sylvia Gong, Christine Vanrenen, Jaren Caine, Mara Giovannetti, Carmel Murone, Fiona E. Scott, Nancy Guo, Ingrid J.G. Burvenich, Cameron Paine, Mary Macri, Masakatsu Kotsuma, Giorgio Senaldi, Ralph Venhaus, Andrew M. Scott
Topics & Concepts
MedicineInternal medicineAdverse effectCohortResponse Evaluation Criteria in Solid TumorsGastroenterologyPharmacokineticsCancerOncologyProgressive diseaseChemotherapyAxon Guidance and Neuronal SignalingHER2/EGFR in Cancer ResearchNeuroblastoma Research and Treatments